સરકારી યોજના , સરકારી ભરતી અને લેટેસ્ટ ન્યૂઝ માટે અમારા વોટ્સઅપ નંબર +91 9723795769 ને તમારા વોટ્સએપ ગ્રુપ માં એડ કરો


Joine whatsApp group

Search This Website

Tuesday 8 December 2020

Serum vaccine will be the cheapest, giving the government a dose of Rs. Preparing to give in 250

Vaccine Tracker: Serum vaccine will be the cheapest, giving the government a dose of Rs. Preparing to give in 250




The government's supply deal will be signed soon
Emergency use approval will also be decided quickly



The Serum Institute of India (SSI), the world's largest vaccine-maker, is to sign a supply-contract for Corona vaccine-Covishield with the central government. According to the company, they have offered the government a dose of Rs. Will give in 250.

The Serum Institute of India (SSI) has sought approval for emergency use for Kovishield in India and a decision will be taken soon, according to government sources. The process of approval of emergency use has already been expedited. If all goes well, vaccination will start in the country from January. Kovishield has been co-produced by Oxford University and AstraZeneca. The Serum Institute in India has conducted its Phase 2/3 trials.

Adar Poonawala, chief executive officer of SSI, had earlier said that a single dose of the vaccine would cost Rs. 1,000. The price will be a bit lower in a big supply deal with the government. It was already said that the government would charge કિંમત 3 or Rs. Will keep 225 to 250. Poonawala also said that his focus would be on supplying vaccines to India first.

Pfizer is also ready to deal with the government.
More than 97 lakh positive cases have been reported in India. India ranks second in the world in terms of positive cases after the US. Pfizer's vaccine is currently seeking emergency use approval in India. However, a single dose of the vaccine costs Rs. Probably around 1450. Pfizer said the price could be slightly lower if the government deals with large quantities of supplies. However, no decision has been taken yet.






Bharat Biotech also seeks approval for emergency use
On the other hand, Bharat Biotech, a Hyderabad-based company that manufactures indigenous vaccine covacin, has also sought approval from the government for its vaccine. The vaccine has been developed in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). No decision has yet been made on what the price will be. However, a single dose of this vaccine costs Rs. 300-400 is likely.

No comments:

Post a Comment